$27.44
0.461.72%
Pre-Market: Nov 20, 4:00 PM EDT
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
First Trust Nasdaq Pharmaceuticals ETF
FTXHNASDAQ
Sector
Healthcare
Region
US
AUM
18.46M
Fund Score
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Quotes, Forecast and News Summary
First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $29.72 |
| AUM | 18.46M |
| Dividend | $0.39 |
| Ex-Div Date | Jun 27, 2024 |
| Volume | - |
| Market Cap | $129.96B |
| Mgmt Fee | 0.6% |
| P/E Ratio | 22.02 |
| Prev. Close | $26.98 |
| Low | - |
| 52 Wk Low | $25.73 |
| Shares Out | 750.00K |
| Yield | 1.38% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 7.75K |
| Beta | 0.66 |
| Avg. Expense Ratio | 0.6% |
| P/B Ratio | 3.36 |
Recent News
FAQ
Q
How do I buy First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock?
A
You can purchase shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) through any online brokerage.
Q
Who are First Trust Nasdaq Pharmaceuticals ETF (FTXH) competitors?
A
There are no as such competitors for First Trust Nasdaq Pharmaceuticals ETF.
Q
What is the forecast, or price target, for First Trust Nasdaq Pharmaceuticals ETF (FTXH) stock?
A
There is no analysis for First Trust Nasdaq Pharmaceuticals ETF to provide a consensus price target.
Q
What is the current price for First Trust Nasdaq Pharmaceuticals ETF (FTXH)?
A
The stock price for First Trust Nasdaq Pharmaceuticals ETF (NASDAQ: FTXH) is $27.44 last updated November 20, 2024 at 4:00 PM EST.
Q
Does First Trust Nasdaq Pharmaceuticals ETF (FTXH) pay a dividend?
A
A quarterly cash dividend of 0.13 per share of Class A Common Stock. The quarterly cash dividend was payable on December 31, 2024 to stockholders of record on December 13, 2024.
Q
When is First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) reporting earnings?
A
First Trust Nasdaq Pharmaceuticals ETF does not have any upcoming earnings scheduled.
Q
Is First Trust Nasdaq Pharmaceuticals ETF (FTXH) going to split?
A
There is no upcoming split for First Trust Nasdaq Pharmaceuticals ETF.
| Open | - |
| High | - |
| 52 Wk High | $29.72 |
| AUM | 18.46M |
| Dividend | $0.39 |
| Ex-Div Date | Jun 27, 2024 |
| Volume | - |
| Market Cap | $129.96B |
| Mgmt Fee | 0.6% |
| P/E Ratio | 22.02 |
| Prev. Close | $26.98 |
| Low | - |
| 52 Wk Low | $25.73 |
| Shares Out | 750.00K |
| Yield | 1.38% |
| Div. Freq | Quarterly |
| Avg. Volume Daily | 7.75K |
| Beta | 0.66 |
| Avg. Expense Ratio | 0.6% |
| P/B Ratio | 3.36 |
ETF Details
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | Sep 20, 2016 |
| Managers | Erik Russo Roger F. Testin David G. McGarel Stan Ueland Jon C. Erickson Daniel J. Lindquist Chris A. Peterson |
| Definition | A Equity Fund portfolio full of stocks with both strong financial performance and superior growth potential |
Investment Policy
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| PFE | Pfizer, Inc. | 7.93% |
| ABBV | Abbvie Inc. | 7.42% |
| JNJ | Johnson & Johnson | 7.08% |
| BMY | Bristol-Myers Squibb C... | 6.64% |
| MRK | Merck & Company, Inc. | 6.26% |
| UTHR | United Therapeutic | 4.63% |
| AMGN | Amgen Inc. | 4.20% |
| VRTX | Nvaesrtex Pharmaceutic... | 4.02% |
| REGN | Regeneron Parmaceutica... | 3.93% |
| GILD | Gilead Sciences Inc | 3.68% |
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved